JACK W. LASERSOHN - 17 Jun 2021 Form 4 Insider Report for Silk Road Medical Inc

Role: Director
Signature: /s/Mhairi Jones, by power of attorney
Issuer symbol: N/A
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2021, 18:39:24 UTC
Previous filing: 04 Jun 2021
Next filing: 13 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Award	$0	+570	+12%	$0.000000	5,339	17 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Award	$0	+4,066		$0.000000	4,066	17 Jun 2021	Common Stock	4,066	$50.40	Direct	F2
transaction	SILK	Option (right to buy)	Award	$0	+4,667		$0.000000	4,667	17 Jun 2021	Common Stock	4,667	$50.40	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F2	All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F3	The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options.
F4	One fourth of the shares subject to the option shall vest on each of September 5, 2021, December 5, 2021, March 5, 2022, and the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.